Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020;23(3):407-409.
doi: 10.1038/s41391-020-0240-4. Epub 2020 May 18.

Elective procedures for prostate cancer in the time of Covid-19: a multidisciplinary team experience

Affiliations
Review

Elective procedures for prostate cancer in the time of Covid-19: a multidisciplinary team experience

Alessandro Sciarra et al. Prostate Cancer Prostatic Dis. 2020.

Abstract

On March 29th 2020, 97,689 cases of COVID-19 have been diagnosed only in Italy, with 73,880 actually positive cases, a daily increase of 3815 cases, 27,386 hospitalized and 3906 patients in intensive care units, causing a total of 10,779 known deaths. In all urological departments, quickly inpatient and outpatient services have been significantly reduced. Even in this COVID-19 situation, urological neoplasm care must go on, but significant changes need to be made in the way some care is delivered. We compared diagnostic and therapeutic elective procedures requested and performed for PC management from our multidisciplinary team (MDT) during 1 month activity in the highest national level of COVID-19 infection (March 2020) and under restrictions for all the population, with the management performed in a no-COVID-19 month (March 2019) 1 year ago. The only management that did not received a significant reduction are medical therapies for advanced hormone sensitive (HS) or castration resistant (CR) PC. We describe our MDT identifications of elective undeferrable PC management in this COVID-19 time. These suggestions have been considered for a country (ITALY) under a rapid increase of COVID-19 cases and complications, but in a region with an actual lower impact (2914 actual positive and 1079 hospitalized cases) from the infection and in an hospital not completely converted to COVID-19 management. Indications should be different and restricted only to emergencies on the basis of COVID-19 pandemic situation and hospital involvement.

Keywords: Cancer therapy; Prostate cancer.

PubMed Disclaimer

Conflict of interest statement

Conflict of interestThe authors declare that they have no conflict of interest.

References

    1. Livingston E, Bucher K. Coronavirus Disease 2019 (COVID-19) in Italy. JAMA. 2020. 10.1001/jama.2020.4344. - PubMed
    1. Kashi AH. COVID-19, urologists and hospitals. Urol J. 2020. 10.22037/uj.v0i0.6064. - PubMed
    1. Nowroozi A, Amini E. Urology practice in the time of COVID-19. Urol J. 2020. 10.22037/uj.v0i0.6065. - PubMed
    1. Ficarra V, Novara G, Abrate A, Bartoletti R, Crestani A, De Nunzio C, et al. Urology practice during COVID-19 pandemic. Members of the Research Urology Network (RUN). Minerva Urol Nefrol. 2020. 10.23736/S0393-2249.20.03846-1.
    1. Chan MC, Yeo SEK, Chong YL, Lee YM. Stepping forwards: urologists’ efforts during the COVID-19 outbreak in Singapore Eur Urol. 2020 Mar. pii: S0302-2838(20)30145-7. 10.1016/j.eururo.2020.03.004. - PMC - PubMed